AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peuhkuri, K.
Right arrow Articles by Teuri, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peuhkuri, K.
Right arrow Articles by Teuri, U.
Agricola
Right arrow Articles by Peuhkuri, K.
Right arrow Articles by Teuri, U.
American Journal of Clinical Nutrition, Vol. 71, No. 2, 600-602, February 2000
© 2000 American Society for Clinical Nutrition


Letters to the Editor

Lactose intolerance—a confusing clinical diagnosis

Katri Peuhkuri, Heikki Vapaatalo, Riitta Korpela and Ulla Teuri

Institute of Biomedicine, Department of Pharmacology and Toxicology, University of Helsinki, PO Box 8, Helsinki FIN-00014, Finland
Foundation for Nutrition Research, PO Box 390, Helsinki FIN-00101, Finland, E-mail: riitta.korpela{at}valio.fi
Valio Ltd, R&D Centre, PO Box 30, Helsinki FIN-00039, Finland

Dear Sir:

We read with interest the paper published recently by Saltzman et al (1) concerning lactose intolerance. We consider it to be of great significance that >40% of the subjects with self-reported lactose intolerance were, according to Saltzman et al (1), lactose digesters.

In Finland, {approx}17% of the population has hypolactasia (2). The Finnish population is very much aware of lactose intolerance because of media coverage. Because milk and milk products are a large part of the Finnish diet, gastrointestinal problems are easily assumed to be caused by milk. Because many lactose maldigesters tolerate small amounts of lactose in their diet without experiencing any gastrointestinal symptoms (3), the concept of lactose intolerance becomes confusing.

Inspired by the interesting results of Saltzman et al (1), we combined our existing data from 4 different studies (47). Over the last few years, 68 subjects (mean age: 35 y; range: 18–65 y; 60 females and 10 males) participated in our blinded crossover trials set up to investigate the biochemical background of lactose intolerance (47). We used the 3 most commonly used lactose tolerance tests in these subjects. The diagnostic variables were as follows: increased blood glucose <=1.1 mmol/L, increased excretion of breath hydrogen >=20 ppm, and excreted urinary galactose <=20 mg/3 h. Thirty-one subjects had previously received a diagnosis of lactose intolerance by a health care professional and the remaining 37 subjects were self-diagnosed. Using our gold standard of >=2 of the 3 diagnostic variables being positive after ingestion of 50 g lactose in 250 or 300 mL water after an overnight fast (10 h), we found only half of the 31 subjects with a previous diagnosis of lactose tolerance and 40% of the 37 self-diagnosed subjects to be lactose maldigesters (Figure 1Go).



View larger version (0K):
[in this window]
[in a new window]
 
FIGURE 1. Distribution of subjects with a previous diagnosis of lactose maldigestion and those self-diagnosed as lactose intolerant according to symptoms and laboratory findings after ingestion of 50 g lactose in a blinded crossover study design in our laboratory. *Positive findings for >=2 of the 3 variables (increase in blood glucose, breath hydrogen, or urinary galactose excretion).

 
Surprisingly, one-third of the 29 subjects diagnosed by us as lactose maldigesters had no clinically significant gastrointestinal symptoms for 3 h after ingesting 50 g lactose. At the same time, one-fourth of the 39 lactose digesters experienced clinically significant gastrointestinal symptoms after ingesting the same amount of lactose. However, the gastrointestinal symptoms differed between the lactose maldigesters and the digesters. Flatulence was the most severe symptom in the maldigesters ({approx}40% of the individual maximum scores) and abdominal bloating was the most severe symptom in the symptomatic digesters (>40% of the individual scores). In both of these groups, the severity of the other symptoms was roughly the same ({approx}20%). Clearly, there is a danger that those lactose digesters who experienced symptoms could receive an incorrect diagnosis of lactose intolerance. Thus, it is essential that the diagnostic tests be conducted carefully.

It is obvious that secondary lactose intolerance due to epithelial damage (secondary hypolactasia) is common. Therefore, the diagnosis of lactose intolerance needs to be made with carefully controlled clinical lactose tolerance tests, preferably more than one. In cases in which values are borderline, a repeat test should be conducted, preferably with use of a different diagnostic method after a period of time. It is hoped that more studies concerning the problems related to the diagnosis of lactose intolerance, like that by Saltzman et al (1), will be carried out.

REFERENCES

  1. Saltzman JR, Russell RM, Golner B, Barakat S, Dallal GE, Goldin BR. A randomized trial of Lactobacillus acidophilus BG2FO4 to treat lactose intolerance. Am J Clin Nutr 1999;69:140–6.[Abstract/Free Full Text]
  2. Sahi T. Lactose malabsorption in Finnish-speaking and Swedish-speaking populations in Finland. Scand J Gastroenterol 1974;9:303–8.[Medline]
  3. Vesa T, Korpela R, Sahi T. Tolerance to small amounts of lactose in lactose maldigesters. Am J Clin Nutr 1996;64:197–201.[Abstract/Free Full Text]
  4. Teuri U, Vapaatalo H, Korpela R. Fructooligosaccharides and lactulose cause more symptoms in lactose maldigesters and subjects with pseudohypolactasia than in control lactose digesters. Am J Clin Nutr 1999;69:973–9.[Abstract/Free Full Text]
  5. Peuhkuri K, Poussa T, Korpela R. Comparison of a portable breath-hydrogen analyser (Micro H2) with a Quintron MicroLyzer in measuring lactose maldigestion, and the evaluation of a Micro H2 for diagnosing hypolactasia. Scand J Clin Lab Invest 1998;58:217–24.[Medline]
  6. Peuhkuri K, Nevala R, Vapaatalo H, Korpela R. Influence of the pharmacological modification of gastric emptying on lactose digestion and gastrointestinal symptoms. Aliment Pharmacol Ther 1999;13:81–6.[Medline]
  7. Peuhkuri K, Nevala R, Vapaatalo H, Moilanen E, Korpela R. Ibuprofen augments gastrointestinal symptoms in lactose maldigesters during a lactose tolerance test. Aliment Pharmacol Ther 1999;13:1227–33.[Medline]



This article has been cited by other articles:


Home page
J. Am. Coll. Nutr.Home page
H. Y. Lovelace and S. I. Barr
Diagnosis, Symptoms, and Calcium Intakes of Individuals with Self-Reported Lactose Intolerance
J. Am. Coll. Nutr., February 1, 2005; 24(1): 51 - 57.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peuhkuri, K.
Right arrow Articles by Teuri, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peuhkuri, K.
Right arrow Articles by Teuri, U.
Agricola
Right arrow Articles by Peuhkuri, K.
Right arrow Articles by Teuri, U.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS